The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viking Therapeutics Inc shares valued at $10,089,164 were sold by ZANTE GREG on Oct 28 ’24. At $76.61 per share, ZANTE GREG sold 131,687 shares. The insider’s holdings dropped to 149,366 shares worth approximately $10.28 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, GREG ZANTE purchased 131,687 shares, netting a total of over 10,275,537 in proceeds.
Before that, Rouan Sarah Kathryn had sold 11,000 shares from its account. In a trade valued at $889,790, the Director traded Viking Therapeutics Inc shares for $80.89 each. Upon closing the transaction, the insider’s holdings decreased to 11,000 shares, worth approximately $0.0.
As published in a research note from H.C. Wainwright on November 04, 2024, Viking Therapeutics Inc [VKTX] has been retained to a Buy and the price target has been revised to $102. Analysts at JP Morgan started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid September. As of June 27, 2024, Morgan Stanley has initiated its “an Overweight” rating for VKTX. Earlier on May 16, 2024, Raymond James upgraded its rating. Their new recommendation was “a Strong buy” for VKTX stock which previously was a “an Outperform”.
Analyzing VKTX Stock Performance
During the last five days, there has been a drop of approximately -5.09%. Over the course of the year, Viking Therapeutics Inc shares have jumped approximately 269.96%. Shares of the company reached a 52-week high of $99.41 on 02/28/24 and a 52-week low of $17.23 on 01/03/24. A 50-day SMA is recorded $64.65, while a 200-day SMA reached $60.69. Nevertheless, trading volume fell to 3.76 million shares from 5.94 million shares the previous day.
Support And Resistance Levels for Viking Therapeutics Inc (VKTX)
According to the 24-hour chart, there is a support level at 66.07, which, if violated, would cause prices to drop to 63.28. In the upper region, resistance lies at 70.37. The next price resistance is at 71.88. RSI (Relative Strength Index) is 52.50 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.52, which suggests the price will decrease in the coming days. Percent R is at 59.30%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
